Marshall Wace
UTMD icon

Marshall Wace’s Utah Medical Products UTMD Stock Holding History

Marshall Wace’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,166
Closed -$233K – 3206
2025
Q1 		$233K Sell
4,166
-7,684
-65% -$460K ﹤0.01% 2356
2024
Q4 		$728K Buy
11,850
+7,019
+145% +$454K ﹤0.01% 1881
2024
Q3 		$323K Buy
+4,831
New +$328K ﹤0.01% 2103
2024
Q2 		– Sell
-4,860
Closed -$346K – 2986
2024
Q1 		$346K Buy
+4,860
New +$365K ﹤0.01% 2062
2019
Q3 		– Sell
-3,673
Closed -$352K – 1942
2019
Q2 		$352K Sell
3,673
-2,377
-39% -$200K ﹤0.01% 1150
2019
Q1 		$534K Sell
6,050
-3,284
-35% -$289K 0.01% 1124
2018
Q4 		$775K Buy
+9,334
New +$822K 0.01% 981

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Marshall Wace's UTMD Position: Q2 2025 in Review

Marshall Wace sold out of Utah Medical Products (UTMD) in Q2 2025, closing a stake of 4,166 shares — an estimated $233K sold.

Marshall Wace first reported a position in UTMD in Q4 2018 and held it in 7 quarters. The position peaked at $775K in Q4 2018. 112 funds tracked by Wall St. Rank hold UTMD as of Q2 2025.

  • Marshall Wace reported no remaining Utah Medical Products position as of Q2 2025 after selling out during the quarter.
  • Marshall Wace sold 4,166 Utah Medical Products shares in Q2 2025, an estimated $233K.
  • Marshall Wace first reported a position in Utah Medical Products in Q4 2018 and held it in 7 quarters.
  • Marshall Wace's Utah Medical Products position peaked at $775K in Q4 2018.
  • 112 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2025.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.